Facebook Linkedin RSS Twitter Youtube
Home 2024

Liver diseases

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Industry News

Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop
Drug Discovery

ASGCT 2024: Gene Therapy Delivery and Development Dominates Opening Workshop

In Vivo Gene Editing Grants Access to Medical Treasures
Genome Editing

In Vivo Gene Editing Grants Access to Medical Treasures

Obesity Due to High-Fat Diet Could Be Reversed by Mitochondria-Targeting Drugs
Drug Discovery

Obesity Due to High-Fat Diet Could Be Reversed by Mitochondria-Targeting Drugs

Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership
Drug Discovery

Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership

Chronic Viral Infections Disrupt B Cells, Degrade Antibody Responses
Featured

Chronic Viral Infections Disrupt B Cells, Degrade Antibody Responses

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles
Drug Discovery

StockWatch: Investors Less Forgiving than Analysts as Verve Tumbles

Six-Fold Obesity Risk in Adults Linked to Rare Genetic Variants
Featured

Six-Fold Obesity Risk in Adults Linked to Rare Genetic Variants

Nanoparticle Uptake Screen Informs Nanomedicine Design
Drug Discovery

Nanoparticle Uptake Screen Informs Nanomedicine Design

StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug
Drug Discovery

StockWatch: Blockbuster Sales Projected for Madrigal MASH Drug

123...48Page 1 of 48
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.